Authors


John H. Merey, MD

Latest:

Ophthalmologist Holocaust survivor shares his story

In observance of International Holocaust Remembrance Day this January 27, John H. Merey, MD, may be the only Holocaust survivor still in the practice of ophthalmology.


Judy Kim, MD

Latest:

Promoting Treatment Adherence in nAMD and DME

Experts discuss the use of steroids, particularly in the context of diabetic macular edema (DME). The inflammatory nature of DME reveals the effectiveness of steroids, especially in cases where persistent fluid remains despite anti-VEGF treatment.


Ashlie Leal

Latest:

Virtual reality brings care to at-need areas

Technology offers accessibility, scalability to countries where care is needed the most.


Haoxing Douglas Jin, MD

Latest:

Ocular manifestations of mycoplasma-induced rash and mucositis

Aggressive lubrication combined with topical steroids, antibiotics boosts chances of recovery.


Sara Giammaria, MD

Latest:

Pivotal study data drive glaucoma patient treatment decisions

Two trials examine factors affecting the risk of disease.


Ferdinand K. Hui, MD

Latest:

Clearing hurdles to large scale telemedicine adoption

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye


Vanita Berry, PhD

Latest:

Focus on molecular mechanisms underlying cataract development

Several hundred genes are associated with congenital forms.


Boris Malyugin, MD, PhD

Latest:

Cataract surgery pearls for cases with poor mydriasis, zonules

Factors that lead to complications must be managed for best outcomes.


Dimitrios Giannoulis, MD

Latest:

Unraveling the genetics of glaucoma

Details enhance knowledge of biological pathways that contribute to disease pathogenesis.


Beeran Meghpara, MD

Latest:

Cyropreserved amniotic membrane option for management of DED, NK

Treatment requires a systematic, multifaceted approach to improve outcomes.


Austin F. Cheng, Esq

Latest:

Payment points: The ASC perspective

Transparent pricing in elective surgeries is crucial.


Cecelia Koetting, OD, FAAO, DipABO

Latest:

Study offering new hope for medical presbyopia correction

BRIO-1 clinical trial sowing optimism as a potential therapeutic option.


Lucas Zago Ribeiro, MD

Latest:

The evolving role of vitreosurgical simulators in surgical training

Need to eliminate errors results in optimization of training of novice surgeons.


Mauricio Maia, MD, PhD

Latest:

The evolving role of vitreosurgical simulators in surgical training

Need to eliminate errors results in optimization of training of novice surgeons.


Lejla Vajzovic, MD, FASRS

Latest:

Unlocking geographic atrophy

Staging AMD accurately and identifying clinical features that are linked with disease progression are key.


Deanna H. Dang

Latest:

Study: IOL calculation remains challenging in PKP eyes

The study assesses and compares the accuracy of IOL formulas using keratometry (K) and total keratometry (TK) values obtained by a swept-source OCT biometer (IOL Master 700) in eyes with previous PKP prior to cataract surgery.


Reena A. Garg, MD

Latest:

XEN continues to evolve for use in glaucoma surgery

Patient-tailored techniques result in predicable outcomes for patients.


Lisa K. Feulner, MD, PhD

Latest:

Advances in cataract surgery show value in tools, tech for surgeons

Three cases demonstrate value of new tools, technology for surgeons.


George Spaeth, MD

Latest:

Glaucoma 45 years later: Much changed, much unchanged

Innovation, change has dominated the glaucoma specialty over the years.


Kelly K. Nichols, OD, MPH, PhD, FAAO

Latest:

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 4 of the Viewpoints Podcast.


John D. Sheppard, MD, MMSc, FACS

Latest:

Are your patients suffering in silence with dry eye disease?

By taking a proactive approach to treatment, ophthalmologists can identify the “silent sufferers.”


Aaron D. Dotson, MD

Latest:

BLOG: Being the change we want to see in ophthalmology

A recent study showed that only 6% of practicing ophthalmologists in the US identify as an underrepresented minority.


Savak Teymoorian, MD

Latest:

Ocular implants can be a gateway to better glaucoma care

Until new innovations began transforming the field a decade ago, ophthalmologists had a limited toolbox. This option allows ophthalmologists to provide positive outcomes for their patients.


Andrew Carey, MD

Latest:

VLOG: NeuroOp Guru: Susac syndrome and fluorescein angiogram

Andrew Lee, MD, and Andrew Carey, MD, sit down on another episode of the NeuroOp Guru to discuss Susac syndrome, and how leakage on fluorescein angiogram might be the most sensitive marker of activity of disease.


Carlton Yuen, MD

Latest:

Depth-of-focus enhancement makes target easier to hit

Lens an option for complicated eyes, astigmatism, monovision candidates.


Bret L. Fisher, MD

Latest:

Comparable conscious sedation methods address individual patient needs

Sublingual troche sedation represents attractive anesthesia option for specific subset of patients with cataracts.



Noha Ekdawi, MD, FAAP

Latest:

Experience with Soft Contact Lenses for Pediatric Myopia

Dr Noha Ekdawi shares her experience using soft contact lenses to combat myopia progression and emphasizes the importance of proactive treatment in managing myopia effectively.


David P. Piñero, PhD

Latest:

Link between neurodevelopmental disorders, visual problems studied

Investigators find that youth show altered ocular movements, reduced amplitude of accommodation.


Michael Mbagwu, MD

Latest:

Intracanalicular corticosteroid insert safe for postsurgical inflammation, pain

Study demonstrates power of IRIS Registry for evaluation of safety, efficacy

© 2024 MJH Life Sciences

All rights reserved.